Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Emma Lorne Graham 20/06/2007 Jonathan Richard Graham 20/06/2007 17 December 2025 The principal activity of the company in the year under review was that of the holding of leasehold property. 06286585 2025-03-31 06286585 bus:Director1 2025-03-31 06286585 bus:Director2 2025-03-31 06286585 2024-03-31 06286585 core:CurrentFinancialInstruments 2025-03-31 06286585 core:CurrentFinancialInstruments 2024-03-31 06286585 core:Non-currentFinancialInstruments 2025-03-31 06286585 core:Non-currentFinancialInstruments 2024-03-31 06286585 core:ShareCapital 2025-03-31 06286585 core:ShareCapital 2024-03-31 06286585 core:RetainedEarningsAccumulatedLosses 2025-03-31 06286585 core:RetainedEarningsAccumulatedLosses 2024-03-31 06286585 core:LeaseholdImprovements 2024-03-31 06286585 core:LeaseholdImprovements 2025-03-31 06286585 core:CurrentFinancialInstruments 1 2025-03-31 06286585 core:CurrentFinancialInstruments 1 2024-03-31 06286585 core:WithinOneYear 2025-03-31 06286585 core:WithinOneYear 2024-03-31 06286585 core:BetweenOneFiveYears 2025-03-31 06286585 core:BetweenOneFiveYears 2024-03-31 06286585 core:MoreThanFiveYears 2025-03-31 06286585 core:MoreThanFiveYears 2024-03-31 06286585 2024-04-01 2025-03-31 06286585 bus:FilletedAccounts 2024-04-01 2025-03-31 06286585 bus:SmallEntities 2024-04-01 2025-03-31 06286585 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 06286585 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 06286585 bus:Director1 2024-04-01 2025-03-31 06286585 bus:Director2 2024-04-01 2025-03-31 06286585 core:LeaseholdImprovements core:BottomRangeValue 2024-04-01 2025-03-31 06286585 core:LeaseholdImprovements core:TopRangeValue 2024-04-01 2025-03-31 06286585 2023-04-01 2024-03-31 06286585 core:LeaseholdImprovements 2024-04-01 2025-03-31 06286585 core:Non-currentFinancialInstruments 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Company No: 06286585 (England and Wales)

PHYSIOFUNCTION (SUPPLIES) LTD

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH THE REGISTRAR

PHYSIOFUNCTION (SUPPLIES) LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025

Contents

PHYSIOFUNCTION (SUPPLIES) LTD

COMPANY INFORMATION

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
PHYSIOFUNCTION (SUPPLIES) LTD

COMPANY INFORMATION (continued)

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
DIRECTORS Emma Lorne Graham
Jonathan Richard Graham
SECRETARY Emma Lorne Graham
REGISTERED OFFICE 1 & 4 Hawthorn Park Holdenby Road
Spratton
Northampton
NN6 8LD
United Kingdom
COMPANY NUMBER 06286585 (England and Wales)
ACCOUNTANT Shaw Gibbs Limited
Eagle House
28 Billing Road
Northampton
NN1 5AJ
PHYSIOFUNCTION (SUPPLIES) LTD

BALANCE SHEET

AS AT 31 MARCH 2025
PHYSIOFUNCTION (SUPPLIES) LTD

BALANCE SHEET (continued)

AS AT 31 MARCH 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 4 69,987 79,075
69,987 79,075
Current assets
Debtors 5 15,195 15,028
Cash at bank and in hand 58,798 57,152
73,993 72,180
Creditors: amounts falling due within one year 6 ( 11,589) ( 9,975)
Net current assets 62,404 62,205
Total assets less current liabilities 132,391 141,280
Creditors: amounts falling due after more than one year 7 0 ( 10,664)
Provision for liabilities 8 ( 6,290) ( 5,272)
Net assets 126,101 125,344
Capital and reserves
Called-up share capital 902 902
Profit and loss account 125,199 124,442
Total shareholders' funds 126,101 125,344

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Physiofunction (Supplies) Ltd (registered number: 06286585) were approved and authorised for issue by the Board of Directors on 17 December 2025. They were signed on its behalf by:

Jonathan Richard Graham
Director
PHYSIOFUNCTION (SUPPLIES) LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
PHYSIOFUNCTION (SUPPLIES) LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Physiofunction (Supplies) Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 1 & 4 Hawthorn Park Holdenby Road, Spratton, Northampton, NN6 8LD, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Taxation

Current tax
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Leasehold improvements 10 - 15 years straight line

Depreciation methods, useful lives and residual values are reviewed at each balance sheet date. The selection of these residual values and estimated lives requires the exercise of judgement. The directors are required to assess whether there is an indication of impairment to the carrying value of assets. In making that assessment, judgements are made in estimating value in use. The directors consider that the individual carrying values of assets are supportable by their value in use.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Leases

The Company as lessee
Assets held under finance leases, hire purchase contracts and other similar arrangements, which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or, if lower, the present value of the minimum lease payments as determined at the inception of the lease) and are depreciated over the shorter of the lease terms and their useful lives. The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the Profit and Loss Account over the period of the leases to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

2. Critical accounting judgements and key sources of estimation uncertainty

The preparation of financial statements requires the use of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying the company accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed within the individual accounting policies below.

3. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

4. Tangible assets

Leasehold improve-
ments
Total
£ £
Cost
At 01 April 2024 122,550 122,550
At 31 March 2025 122,550 122,550
Accumulated depreciation
At 01 April 2024 43,475 43,475
Charge for the financial year 9,088 9,088
At 31 March 2025 52,563 52,563
Net book value
At 31 March 2025 69,987 69,987
At 31 March 2024 79,075 79,075

5. Debtors

2025 2024
£ £
VAT recoverable 2,295 2,128
Other debtors 12,900 12,900
15,195 15,028

6. Creditors: amounts falling due within one year

2025 2024
£ £
Bank loans 7,870 7,951
Amounts owed to connected companies 3,539 1,845
Other creditors 180 179
11,589 9,975

7. Creditors: amounts falling due after more than one year

2025 2024
£ £
Bank loans 0 10,664

There are no amounts included above in respect of which any security has been given by the small entity.

8. Provision for liabilities

2025 2024
£ £
Deferred tax 6,290 5,272

9. Financial commitments

Commitments

Total future minimum lease payments under non-cancellable operating leases are as follows:

2025 2024
£ £
within one year 45,000 40,000
between one and five years 180,000 160,000
after five years 225,000 240,000
Total future minimum lease payments under non-cancellable operating leases 450,000 440,000